Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | 2 | GRO-a | 150.0 | 59 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | GRO-a | 51.0 | 63 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | GRO-a | 48.0 | 45 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | GRO-a | 624.0 | 44 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | GRO-a | 312.0 | 57 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | GRO-a | 192.5 | 54 | ||||
RA2159 | 2 | GRO-a | 271.0 | 45 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | GRO-a | 76.0 | 45 | ||||
N2645 | 2 | GRO-a | 72.5 | 42 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | GRO-a | 1799.0 | 38 | ||||
RA2708 | 2 | GRO-a | 2356.0 | 47 | |||||||
0 | GRO-a | 41.0 | 34 | ||||||||
0 | GRO-a | 45.0 | 39 | ||||||||
0 | GRO-a | 42.0 | 41 | ||||||||
0 | GRO-a | 31.0 | 54 | ||||||||
0 | GRO-a | 43.0 | 31 | ||||||||
0 | GRO-a | 48.0 | 29 | ||||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | GRO-a | 49.0 | 52 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | GRO-a | 40.0 | 73 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | GRO-a | 843.0 | 62 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | GRO-a | 985.5 | 52 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | GRO-a | 106.0 | 61 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | GRO-a | 136.0 | 64 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | GRO-a | 282.5 | 70 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | GRO-a | 287.0 | 49 |